Litigation Details for Teva Pharmaceuticals USA, Inc. v. Synthon Pharmaceuticals, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Teva Pharmaceuticals USA, Inc. v. Synthon Pharmaceuticals, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-04-07 |
| Court | District Court, D. Delaware | Date Terminated | 2017-12-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 8,232,250; 8,399,413; 8,969,302; 9,155,776; 9,402,874 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Teva Pharmaceuticals USA, Inc. v. Synthon Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Teva Pharmaceuticals USA, Inc. v. Synthon Pharmaceuticals, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-06-05 | 82 | regarding four patents related to the now-dismissed ’874 patent: 7 U.S. Patent Nos. 8,232,250 (“the ’250…250 patent”), 8,399,413 (“the ’413 patent”), 8,969,302 (“the ’302 patent”), and 9,155,776 (“the ’776 patent…IPR2015-00643 (’250 patent); IPR2015-00644 (’413 patent); IPR2015-00830 (’302 patent). The P.T.A.B.’s decision…actions concern the same patent, and in Teva’s actions asserting the ’775 patent, the Defendants have asserted… and Service These patent infringement suits arise under the Patent Laws of the United States, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
